Both in Pharmaceuticals
Sarepta Therapeutics, vs SELLAS Life Sciences Group
Over the past year SRPT returned −25.4% and SLS returned +384.4%; their daily moves had a correlation of 0.23.
SRPT −25.4% SLS +384.4%Growth of $1, one year, split-adjusted
| Metric | SRPT | SLS |
|---|---|---|
| Price | $18.23 | $8.67 |
| Market cap | $1.93B | $1.75B |
| Today | −2.09% | −10.43% |
| 1 month | +4.2% | −26.1% |
| 6 months | −17.3% | +72.7% |
| Year to date | −15.3% | +130.0% |
| 1 year | −21.6% | +353.9% |
| Revenue growth (YoY) | −34.3% | — |
| Gross margin | 62.8% | — |
| Net margin | −1.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | -$59.1M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 97.1% |
| Short % of float | 22.7% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).